Search - tctmd.com

Displaying 661 - 680 of 2240

Sort: Relevancy | Date

News Daily News

DES、BMS 均适合治疗患隐静脉桥血管病变的患者

July 20, 2015

News Daily News

DES, BMS Both Suitable for Treating Patients With SVG Lesions

July 20, 2015

News Industry News

Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology

July 20, 2015

Presentation

Safety and Clinical Effectiveness of DES for SVG Intervention in Older Individuals

Presenter: J. Matthew Brennan

July 17, 2015

Presentation

High-Sensitivity C-Reactive Protein Predicts 10-Year Cardiovascular Outcome After PCI

Presenter: RM. Oemrawsingh

July 17, 2015

News Industry News

Blue Cross Blue Shield Association Study Reveals Significant Cost Variations for Angioplasties

July 17, 2015

News Daily News

Un Meta Análisis Confirma que las PCI Sin Soporte Quirúrgico son Seguras

July 16, 2015

News Daily News

Meta-analysis Confirms Safety of PCI without Surgical Backup

July 16, 2015

News Daily News

Meta 分析证实 PCI 在无外科手术备选方案时同样安全

July 16, 2015

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

News Industry News

QT Vascular Announces The Allowance Of Four New Patents

July 15, 2015

Presentation

PCI at Centers With and Without On-site Surgical Backup

Presenter: JM. Lee

July 15, 2015

News Industry News

Cardiovascular Systems Completes Coast Study Enrollment

July 14, 2015

News Industry News

Thoratec Receives CE Mark Approval For HeartMate PHP™

July 13, 2015

Presentation

Stroke in the TOTAL Trial: A Randomized Trial of Routine Thrombectomy vs PCI Alone in STEMI

Presenter: Sanjit S. Jolly

July 13, 2015

Presentation

Keynote Lecture I:Evolution of InterventionalTherapies and Future Directions

Presenter: Raoul Bonan

July 11, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

Advertisement

DES、BMS 均适合治疗患隐静脉桥血管病变的患者

DES, BMS Both Suitable for Treating Patients With SVG Lesions

Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology

Safety and Clinical Effectiveness of DES for SVG Intervention in Older Individuals

High-Sensitivity C-Reactive Protein Predicts 10-Year Cardiovascular Outcome After PCI

Blue Cross Blue Shield Association Study Reveals Significant Cost Variations for Angioplasties

Un Meta Análisis Confirma que las PCI Sin Soporte Quirúrgico son Seguras

Meta-analysis Confirms Safety of PCI without Surgical Backup

Meta 分析证实 PCI 在无外科手术备选方案时同样安全

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

QT Vascular Announces The Allowance Of Four New Patents

PCI at Centers With and Without On-site Surgical Backup

Cardiovascular Systems Completes Coast Study Enrollment

Thoratec Receives CE Mark Approval For HeartMate PHP™

Stroke in the TOTAL Trial: A Randomized Trial of Routine Thrombectomy vs PCI Alone in STEMI

Keynote Lecture I:Evolution of InterventionalTherapies and Future Directions

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content